DRAXXIN® provides the single dose convenience you want. The effectiveness you need.
DRAXXIN® (tulathromycin) Injectable Solution is a unique, novel treatment that delivers:
Superior efficacy to treat BRD when compared with Baytril®, Nuflor® and Micotil® in field studies.1,2,3,6
Convenient, full course of therapy in a single dose.
Effectiveness against the four major BRD pathogens.
Mannheimia (Pasteurella) haemolytica
Pasteurella multocida
Histophilus somni (Haemophilus somnus)
Mycoplasma bovis
DRAXXIN, tulathromycin, is the first entry of a novel macrolide subclass, the triamilides, developed by Pfizer Animal Health. DRAXXIN is now the first-line product-of-choice to treat pneumonia, offering both superior disease treatment as well as outstanding efficacy for the control of pneumonia in cattle at high risk of developing the disease.